TY  - BOOK
AU  - Alice Saber Gerges
AU  - Eman Elghroury , 
AU  - Inas Ismail Raafat , 
AU  - Mai Mahmoud Sherif , 
TI  - Glypican 3 as a novel marker for Hepatocellular carcinoma / 
PY  - 2013///
CY  - Cairo : 
PB  - Alice Saber Gerges , 
KW  - Glypican 3
KW  - Hepatocellular carcinoma
KW  - Real time PCR
N1  - Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology; Issued also as CD
N2  - Most of patients with HCC are diagnosed at a late stage. Therefore, the prognosis of HCC patients is generally very poor. Alpha.fetoprotein has been widelly used , but its sensitivity has not been satisfactory , in addition to its non-specific elevation innon malignant hepatic diseases. Glypican 3, this protein(GPC3) is over-expressed in HCC, and not in normal hepatocytes and non-malignant liver disease
ER  -